Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system

J J Hwang1, L Li, W F Anderson

  • 1Gene Therapy Laboratories, Norris Cancer Center, University of Southern California School of Medicine, Los Angeles 90033, USA.

Journal of Virology
|September 1, 1997
PubMed
Summary

Researchers created a new conditional self-inactivating (C-SIN) vector, TL-SN, for gene therapy. This novel vector achieves high viral titers using a tetracycline-responsive expression system, enhancing its potential for human applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does pure robotic partial nephrectomy provide similar perioperative outcomes when compared to the combined laparoscopic-robotic approach?

Journal of robotic surgery·2016
Same author

p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.

Cell death and differentiation·2013
Same author

SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment.

Oncogene·2012
Same author

Mönckeberg's sclerosis.

Acta clinica Belgica·2010
Same author

Biodistribution of phenylboric acid derivative entrapped lipiodol and 4-borono-2-18F-fluoro-L-phenylalanine-fructose in GP7TB liver tumor bearing rats for BNCT.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2010
Same author

Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors.

Eye (London, England)·2009

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Development of safe and efficient gene delivery vectors is crucial for gene therapy.
  • Self-inactivating (SIN) vectors reduce the risk of insertional mutagenesis.
  • Conditional gene expression systems offer precise control over transgene expression.

Purpose of the Study:

  • To develop a novel conditional self-inactivating (C-SIN) vector, TL-SN.
  • To engineer a packaging cell line for high-titer virus production.
  • To evaluate the potential of the C-SIN vector for human gene therapy applications.

Main Methods:

  • Modification of the Moloney murine leukemia virus 3' long terminal repeat (LTR) with a synthetic tetracycline operator-cytomegalovirus promoter (tetP).
  • Stable integration of a chimeric transactivator (tTA) into PA317 amphotropic packaging cells to create PA317-tTA cells.

Related Experiment Videos

  • Generation and titration of C-SIN amphotropic virus particles via transinfection.

    • Main Results:

    • High viral titers (2 x 10(5) CFU/ml) of C-SIN amphotropic virus were achieved within 2 days.
    • Titer was approximately 2 log units higher than with parental PA317 cells.
    • Enhanced viral transcript levels in the presence of tTA, originating from the tetP promoter.

    Conclusions:

    • The novel TL-SN C-SIN vector, combined with the PA317-tTA packaging cell line, enables high-titer virus production.
    • The vector exhibits conditional expression due to the tetracycline-responsive expression system (TRES).
    • This C-SIN vector holds significant potential for human gene therapy due to its safety features and efficient production.